Ardelyx, Inc. (ARDX) Price Prediction & ForecastARDXArdelyx, Inc.

Alphio's ARDX stock price prediction model matches the current Ardelyx, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.27 (+0.06%). The 1-week path is $3.37 (+3.18%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Currently, Ardelyx Inc (ARDX) is not a good buy. The stock is trading at $3.28, significantly below its 200-day simple moving average of $5.574, indicating a bearish trend. Additionally, the RSI is at 31.853, suggesting that the stock is oversold but may continue to face downward pressure. The company is also dealing with negative catalysts, including a recent legal setback regarding Medicare coverage for its drug Xphozah, which could impact future revenues. The stock has seen a year-to-date decline of 46.67%, and hedge funds have increased selling by 129.11% over the last quarter, indicating a lack of confidence among institutional investors. The main risk is the ongoing class action lawsuit against the company, which could further affect its stock price.

Ardelyx, Inc. (ARDX) last closed at $3.27, gaining +2.51%. These facts feed the 1-day and 1-week ARDX price prediction above.